Post Tagged with: "Immunotherapy"

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

Oncology October 24, 2017 at 8:28 AM 0 comments

Elena Niccolai,1 Antonio Taddei,1,3 Federica Ricci,2 Maria Novella Ringressi,1,3 *Amedeo Amedei2 1. Department of Surgery and Translational Medicine, University of Florence, Florence, Italy 2. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 3. Department of Biomedicine, Azienda Ospedaliera Universitaria Careggi (AOUC), Florence, Italy *Correspondence to aamedei@unifi.it Disclosure:Read More

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Oncology October 24, 2017 at 8:23 AM 0 comments

Aline N. Zouk, *Hitesh Batra Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA *Correspondence to hbatra@uabmc.edu Disclosure: The authors have declared no conflicts of interest. Received: 19.06.17 Accepted: 18.09.17 Citation: EMJ Oncol. 2017;5[1]:103-111. Abstract Pleural malignancies constitute either primary pleural malignancies, such asRead More

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

European Medical Journal, Hematology August 31, 2017 at 8:14 AM 0 comments

*David Pesántez,1 Adela Rodriguez,1 Aina Oliver-Caldés,2 Pablo Mozas,2 Jordi Esteve2-4 1. Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain 2. Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain 3. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 4. University of Barcelona, Barcelona, Spain *Correspondence to pesantez@clinic.cat Disclosure:Read More

The Use of Emerging Technologies in Allergen Immunotherapy Management

The Use of Emerging Technologies in Allergen Immunotherapy Management

Allergy & Immunology August 3, 2017 at 8:24 AM 0 comments

*Giovanni Melioli, Anna Maria Riccio, Sabina Ledda, Giovanni Passalacqua, Giorgio Walter Canonica Department of Internal Medicine, University of Genova, Genova; Humanitas University, Milan, Italy *Correspondence to giovannimelioli@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 27.03.17 Accepted: 17.07.17 Citation: EMJ Allergy Immunol. 2017;2[1]:81-86. Abstract Emerging technologies are profoundlyRead More

Oral Immunotherapy for Food Allergy: What Have We Achieved So Far?

Oral Immunotherapy for Food Allergy: What Have We Achieved So Far?

Allergy & Immunology August 3, 2017 at 8:22 AM 0 comments

*Katherine Anagnostou Texas Children’s Hospital, Department of Pediatrics, Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, Texas, USA *Correspondence to Aikaterini.Anagnostou@bcm.edu Disclosure: The author has declared no conflicts of interest. Received: 19.01.17 Accepted: 12.07.17 Citation: EMJ Allergy Immunol. 2017;2[1]:94-99. Abstract The burden of food allergy is significant, multi-faceted,Read More

Treatment Opportunities for Colorectal Liver Metastases

Treatment Opportunities for Colorectal Liver Metastases

European Medical Journal, Hepatology April 5, 2016 at 8:49 AM 0 comments

*Tormod Lund Surgical Department, Vestre Viken Hospital Trust, Drammen, Norway. *Correspondence to tolund@vestreviken.no Disclosure: The author has declared no conflicts of interest. Received: 05.02.16 Accepted: 10.03.16 Citation: EMJ. 2016;1[2]:76-83. Abstract Colorectal liver metastases (CLM) are the most common hepatic malignancy and are caused by disseminated tumour cells (DTCs) seeded earlyRead More

Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment

Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment

Oncology November 17, 2014 at 9:47 AM 0 comments

*Letizia Polito, Massimo Bortolotti, Stefania Maiello, Maria Giulia Battelli, Andrea Bolognesi Department of Experimental, Diagnostic, and Specialty Medicine – DIMES, Alma Mater Studiorum – University of Bologna, Bologna, Italy *Correspondence to letizia.polito@unibo.it Disclosure: No potential conflict of interest. Received: 01.04.14 Accepted: 18.06.14 Citation: EMJ Oncol. 2014;2:63-69. Abstract Non-Hodgkin’s lymphomas (NHLs)Read More

Overcoming Immunodeficiency in Chronic Lymphocytic Leukaemia: Current Knowledge and Perspectives

Overcoming Immunodeficiency in Chronic Lymphocytic Leukaemia: Current Knowledge and Perspectives

Hematology July 31, 2014 at 9:58 AM 0 comments

Fabienne McClanahan,1,2 *John Gribben1 1. Barts Cancer Institute, Centre for Haemato-Oncology, Queen Mary University of London, London, UK 2. German Cancer Research Center (DKFZ), Heidelberg, Germany *Correspondence to j.gribben@qmul.ac.uk Disclosure: Fabienne McClanahan has no financial disclosures, and John Gribben is receiving Celgene Research Funding, Pharmacyclics Honoraria, and Roche Honoraria. Support:Read More

Recombinant Allergens in Diagnosis and Therapy of Allergic Diseases

Recombinant Allergens in Diagnosis and Therapy of Allergic Diseases

Respiratory October 2, 2013 at 8:28 PM 0 comments

Alessandra Scaparrotta,1 Anna Cingolani,1 Marina Attanasi,1 Marzia Cerasa,1 Rita Nigro,1 Sabrina Di Pillo,1 Francesco Chiarelli2 1. Allergy and Respiratory Unit, Department of Paediatrics, University of Chieti, Italy 2. Department of Paediatrics, University of Chieti, Italy Disclosure: No potential conflict of interest. Received: 18.07.13 Accepted: 02.10.13 Citation: EMJ Respir. 2013;1:101-107. Abstract The component-resolvedRead More